PAI Partners
PAI Partners makes fresh bid for Refresco
Non-binding €1.4bn takeover proposal was rejected by the Dutch bottles business in April
Politics and private equity – the revolving doors
François Fillon is the latest in a long line of politicians to make the move to private equity
PAI Partners mulls €4bn fund launch by year-end
GP plans a quick return to the fundraising trail, following a busy 24 months in the wake of its previous close
CVC, PAI buy Permira's Grupo Cortefiel stake
Following the transaction, the GPs are understood to retain an equally-split stake in the business
Carlyle acquires ADB Safegate from PAI Partners
Carlyle is investing from its €3.75bn mid-market vehicle Carlyle Europe Partners IV, closed in 2015
PAI to sell DomusVi to ICG and SRS
GP will fully exit the investment to ICG and SRS after three years of ownership
Advent in exclusivity over IPH acquisition from PAI
Following the proposed deal, IPH would merge with UK-based Advent portfolio company Brammer
PAI enters exclusivity with Ergon for EliTech SBO
Ergon bought the medical equipment maker in 2010 in a deal valued at more than €100m
Benelux's packaging firms playing hard to get with PE
Failed take-private efforts by GPs have meant activity in the region has remained dominated by small-cap and lower-mid-market deals
PAI offer rejected by Refresco
Soft drink and fruit juice bottling company rejects the private equity firm's takeover offer
PAI bidding to acquire CD&R's Exova
Two other suitors are also eyeing the laboratory testing business, which has a market cap of £550m
Bain Capital reduces Maisons du Monde stake
GP reduces its stake in the group from 31.2% to 15.8% through the transaction
PAI exits Cerba Healthcare in sale to Partners Group
PAI is exiting the group after a six-year holding, during which Cerba's turnover tripled
PAI-backed Ethypharm acquires Martindale Pharma
New combined entity will generate revenues in excess of €300m
PAI Partners sells Xella to Lone Star for €2.2bn
GP's have sold their portfolio company after an eight-year holding period
unquote" LP and secondaries round-up
An overview of recent news and events regarding private equity LPs and secondaries deals
Palamon sells Sarquavitae to PAI portfolio company
Palamon reaps €140m in proceeds for a 3x money return following the sale to PAI
Gilde sells Roompot Vakanties to PAI Partners
BNP Paribas Fortis, a co-investor alongside Gilde, is also exiting the group
EQT in €830m Atos Medical exit to PAI
PAI Partners becomes the third private equity owner of Atos, following EQT and Nordic Capital
Bain-backed Maisons du Monde in €769m IPO
Bain Capital acquired a majority stake in the French home decoration group for €680m in 2013
Deal in Focus: Astorg sells Ethypharm after nine-year holding
Resisting regular suitors, the GP's nine-year tenure of the pharmaceutical company allowed it to fully implement a long-term acquisitive strategy
PAI in €725m deal to acquire Ethypharm from Astorg
Deal comes nine years after Astorg acquired a 60% stake in the company via the Astorg IV fund
PAI Partners in partial exit from Kaufman & Broad
Holding Financiere Gaillon 8 reaps €257m from the sale of a 39% stake in the business
PAI's R&R merges with Nestlé's ice cream activities
New company, to be called Froneri, will be headquartered in the UK